MIA researchers play a significant role in expanding world knowledge about melanoma. We’ve compiled a list of all recent publications so you can access all MIA research papers in one place.
Georgina V. Long, Charlie Garnett-Benson, Sonia Dolfi, Paolo A. Ascierto, Jun Guo, Ahmad A. Tarhini, Sunandana Chandra, Eva Muñoz-Couselo, Michele Del Vecchio, Andreia Cristina de Melo9, Margaret Callahan, Helen Gogas, Reinhard Dummer, Dirk Schadendorf, Peter Koelblinger, Gaelle Quereux, Ioannis Thomas, Jia Xin Yu, Andrew Fisher, Bonnie Wang, Patrick Djidel, Armand Chouzy, Mark Semaan, Bohang Chen, Alicia M. Y. Cheong & Hussein A. Tawbi, Nature medicine, (18 Oct 2025) doi: 10.1038/s41591-025-04032-8.
Andrea Boutros, Amelia M Taylor, Isabel Li, Nurudeen A Adegoke, Terence Wong, Alexander H R Varey, Kerwin F Shannon, Sydney Ch’ng, Robyn P M Saw, Thomas Pennington, Jonathan Stretch, Andrew Spillane, Alexander C J van Akkooi, Richard A Scolyer, Ines Pires da Silva, Matteo S Carlino, Georgina V Long, Serigne N Lo, Alexander M Menzies. European Journal of Cancer, (16 Oct 2025) doi: 10.1016/j.ejca.2025.115782.
Vergara IA, Lo SN, Li I, Conway JW, Fu X, Menzies AM, Carlino MS, Scolyer RA, Long GV, da Silva IP. Immunooncol Technol. 2025 Oct 15;28:101078. doi: 10.1016/j.iotech.2025.101078. PMID: 41282529; PMCID: PMC12637396.
Meredith M Regan, Paolo A Ascierto MD, Evan J Lipson, Jennell Palaia, Andriy Moshyk, Abraham Selvan, Christopher D Lao, Michael B Atkins MD, David F McDermott, Ravi Potluri, Sandip Ranjan, Sandeep Bilthare, Georgina V Long, F Stephen Hodi, Hussein Tawbi, Dirk Schadendorf. Journal for ImmunoTherapy of Cancer (12 Sept 2025);13: e012747. doi: 10.1136/jitc-2025-012747.
Clarke EL, Magee D, Newton-Bishop J, Merchant W, Insall R, Maher NG, Scolyer RA, Farnworth G, Ali A, O’Shea S, Treanor D. Arch Pathol Lab Med, (Sep 1 2025), doi:10.5858/arpa.2024-0094-OA.
Thompson JF, Uren RF, London K, Chung D, Saw RP, Spillane AJ, Stretch JR, Shannon KF, Howle J, Nieweg OE, Ch’ng S, Pennington TE, Potter AJ, Scolyer RA, Williams GJ. European Journal of Surgical Oncology, 2025 Sep;51(9):110225. doi: 10.1016/j.ejso.2025.110225. PMID: 40614343
A. Arance, M.-A. Berciano Guerrero, J. Guo, M.S. Carlino, P.A. Ascierto, M. Burotto, L. Mortier, P. Queirolo, V. Chiarion-Sileni, J. Schachter, X. Zhang, J. Martin-Liberal, M. Del Vecchio, C.E. Okpara, C. Dutcus, J. Zhang, S.J. Diede, T. Neff, G.V. Long “Randomized, double-blind, phase III LEAP-003 study of first-line lenvatinib plus pembrolizumab versus placebo plus pembrolizumab for unresectable or metastatic melanoma.” Annals of Oncology (28 Aug 2025) doi: 10.1016/j.annonc.2025.08.008.
Wong T, Ch’ng S, Ferguson P, Martin L, Menzies A, Pires da Silva I, Long GV , Scolyer RA, van Akkooi A*, Lo SN* (*contributed equally), Critical Reviews in Oncology/Hematology (20 Jun 2025) doi: 10.1016/j.critrevonc.2025.104816.
Mandalà M, Amaral T, Rutkowski P, Sergi MC, Rasch M-L, Benannoune N, Serra P, Vitale MG, Giannarelli D, Arance AM, Couselo EM, Neyns B, Dirven I, Tucci M, Guida M, Spagnolo F, Rossi E, Queirolo P, Quaglino P, Depenni R, Placzke J, Giacomo AMD, Del Vecchio M, Indini A, Silva IPd, Menzies AM, Hong A, Lorigan P, Long GV, Robert C, Ascierto PA. European Journal of Cancer, 225(Jul 25 2025): 115567, doi:https://doi.org/10.1016/j.ejca.2025.115567.
Wu L, Tsang V, Clifton-Bligh R, Carlino MS, Tse T, Huang Y, Oatley M, Cheung NW, Long GV, Menzies AM, Gunton J. J Immunother Cancer, 13, no. 6, (Jun 8 2025), doi:10.1136/jitc-2024-011271.
For earlier research papers, prior to 2021, please email digital@melanoma.org.au.
